Function
Locations
Dephosphorylate UMP/CMP to uridine/cytidine.
Pyrimidine nucleotides are degraded through a sequence of dephosphorylation, deamination and phosphorolysis that liberates the free bases uracil and thymine, followed by the three-step reductive ring-opening pathway that converts them to beta-alanine and beta-aminoisobutyrate. Pyrimidine mononucleotides (UMP, CMP) are dephosphorylated to uridine and cytidine by the erythrocyte-enriched cytosolic pyrimidine 5'-nucleotidase NT5C3A. Cytidine (and 2'-deoxycytidine) is deaminated to uridine (2'-deoxyuridine) by cytidine deaminase CDA. Uridine is phosphorolysed to uracil plus ribose-1-phosphate by uridine phosphorylase UPP1 (ubiquitous) or UPP2 (tissue-restricted paralog); thymidine is analogously phosphorolysed to thymine by thymidine phosphorylase TYMP. The liberated uracil and thymine then enter the conserved reductive catabolic pathway: dihydropyrimidine dehydrogenase DPYD reduces them (NADPH) to dihydrouracil/dihydrothymine, dihydropyrimidinase DPYS hydrolyses the ring to N-carbamyl-beta-alanine / N-carbamyl-beta-aminoisobutyrate, and beta-ureidopropionase UPB1 releases beta-alanine / beta-aminoisobutyrate (+ CO2 + NH3). This pathway also governs the activation and inactivation of pyrimidine-analog drugs: NT5C3A/CDA/UPP1/TYMP shape the fluoropyrimidine (5-FU, capecitabine) and cytidine-analog (gemcitabine, cytarabine) response, and DPYD loss-of-function causes severe 5-fluorouracil toxicity. Other deficiencies cause pyrimidine-5'-nucleotidase hemolytic anemia (NT5C3A), MNGIE (TYMP), and dihydropyrimidinuria (DPYD/DPYS/UPB1).
All recommended fields populated.
✗ none found
No MODULE:pyrimidine_nucleotide_catabolism deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
8 complete review(s) · 0 with deep research · 0 missing review · 8 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| CDA P32320 | ✓ | ✓ | ✗ |
| DPYD Q12882 | ✓ | ✓ | ✗ |
| DPYS Q14117 | ✓ | ✓ | ✗ |
| NT5C3A Q9H0P0 | ✓ | ✓ | ✗ |
| TYMP P19971 | ✓ | ✓ | ✗ |
| UPB1 Q9UBR1 | ✓ | ✓ | ✗ |
| UPP1 Q16831 | ✓ | ✓ | ✗ |
| UPP2 O95045 | ✓ | ✓ | ✗ |
Pyrimidine nucleotide catabolism (GO:0006244 -> GO:0006212 -> GO:0019483), grounded to nine completed human gene reviews (four new: NT5C3A/CDA/UPP1/UPP2; five already-merged cited as nodes: TYMP PTHR10515, DPYD PTHR43073, DPYS PTHR11647, UPB1 PTHR43674). Route: UMP/CMP -> uridine/cytidine (NT5C3A Q9H0P0 PTHR13045, GO:0008253); cytidine -> uridine (CDA P32320 PTHR11644, GO:0004126, Zn2+); uridine -> uracil + R1P (UPP1 Q16831 / UPP2 O95045 PTHR43691, GO:0004850); thymidine -> thymine (TYMP P19971, GO:0009032); then the conserved reductive branch uracil/thymine -> dihydro (DPYD Q12882, GO:0017113, NADPH) -> N-carbamyl-beta- amino acids (DPYS Q14117, GO:0004157) -> beta-alanine/beta-aminoisobutyrate (UPB1 Q9UBR1, GO:0003837). All cytosolic. Curation notes from the new reviews: NT5C3A's two GO:0000215 tRNA-2'-phosphotransferase annotations are legacy mis-mappings (it is a pyrimidine 5'-nucleotidase, not the tRNA-splicing enzyme) -> flagged; CDA's direct substrates are the nucleosides not CMP/dCMP (monophosphate BP terms demoted); obsolete GO:0009972 "cytidine deamination" avoided; UPP2's vimentin/intermediate-filament IDA traces to a UPP1 paper predating UPP2 cloning (paralog mis-attribution, flagged MISCITED). This pathway also drives fluoropyrimidine (5-FU/capecitabine) and cytidine-analog (gemcitabine/cytarabine) drug metabolism; DPYD LOF -> 5-FU toxicity, NT5C3A -> hemolytic anemia, TYMP -> MNGIE, DPYD/DPYS/UPB1 -> dihydropyrimidinuria. GO term ids/labels verified against the local go.db; module passes structural + term-label validation.
Dephosphorylate UMP/CMP to uridine/cytidine.
Deaminate cytidine to uridine.
Phosphorolyse uridine to uracil + ribose-1-phosphate.
Phosphorolyse thymidine to thymine + deoxyribose-1-phosphate.
Reduce uracil/thymine to dihydrouracil/dihydrothymine.
Hydrolyse the dihydropyrimidine ring to N-carbamyl-beta-amino acids.
Release beta-alanine/beta-aminoisobutyrate (+ CO2 + NH3).